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1N1 Epidemic: Our experience at PGIMER Delhi, India
. yadav ∗, T. samra, M. pawar
Dr. RML Hospital,PGIMER, New Delhi, India
Background: Patients infected with the H1N1 strain of
he inﬂuenza A virus frequently develop rapidly progressive
ower respiratory tract disease resulting in respiratory fail-
re. We describe the clinical characteristics of patients who
xpired in ICU at our hospital in Delhi, India. We did the
tudy to see cause and pattern of death in H1N1.
Methods: Using guidelines developed by the Indian
ealth ministry, all individuals with ﬂu-like symptoms were
creened by a physician into three management categories-
ategory A (out-patient treatment and home isolation),
ategory B (hospital isolation ward) and Category C (inten-
ive care units) based on clinical presentation. Of the 236
atients with conﬁrmed H1N1 evaluated between 8th August
o 27th October 2009 at our facility, 26 patients expired.
ata was collected from the hospital records for patients
ith H1N1, who expired in the ICU. Inﬂuenza A (H1N1) virus
nfection was conﬁrmed in specimens using TaqMan real-
ime reverse transcriptase-polymerase-chain-reaction (CDC
rotocol).
Results: Median age was 29 years (Range: 12 - 74); >80%
f patients were < 40 years. Three (11.5%) were diabetic, 2
7. 7%) pregnant, 5(19.2%) hypertensive, 2(7. 7%) had preex-
sting respiratory disease and 14 (53.9%) had no pre-existing
edical conditions. 24 (92.3%) had primary viral pneumoni-
is and 2 (7.7%) had exacerbation of structural respiratory
isease. 14 (53.9%) developed acute respiratory distress
yndrome (ARDS), 4(15.4%) developed multi organ dysfunc-
ion syndrome (MODS), 3 (11.5%) developed acute renal
ailure (ARF), 2(7.7%) developed myocarditis/Congestive
eart failure (CHF) and 3(11.5%) developed disseminated
ntravascular coagulopathy (DIC).All 26 required mechanical
entilation. Oseltamivir administration delay ranged from 3
o 10 days after illness onset, 52.78% received high-dose
300mg/day) treatment, and treatment duration ranged
rom 1 to 10 days (mean 3.0± 2.5days).
Conclusion: Over a 12 week period, H1N1 virus infec-
ion caused ICU deaths in 26 adult patients with a high case
atality rate of 26/236 (11.0%). Deaths resulted from organ
ailures including ARDS, MODS, ARF, DIC and CHF. Clinicians
hould be aware of the severe organ complications of H1N1,
articularly in pregnant and previously healthy young adults
oi:10.1016/j.ijid.2010.02.1699
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eaths in women during fertile years and pregnant women
s conﬁrmed for pandemic inﬂuenza A (H1N1) in the state
f São Paulo
. Ribeiro ∗, G.D. Freitas, A.C.G. Pellini, T.R.M.P.
arvalhanas, A.L.F. Yu, B.D.L. Liphaus, M.D.C.S.T.
imenetskyState Secretary of Health of Sao Paulo, Sao Paulo, SP, Brazil
Background: Since 16 July, the new inﬂuenza virus A
H1N1) was considered widespread in Brazil. Some groups
b
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‘ternational Congress on Infectious Diseases (ICID) Abstracts
ad more serious evolution, with higher hospitalization and
ortality rates. The risks for complications and deaths were
igher in children under two years of age, young adults,
atients of chronic diseases and pregnant women.
Methods: Analysis was performed to identify factors
ssociated with death among conﬁrmed cases of inﬂuenza
/H1N1 in women during their fertile years (WFY:10-49 years
f age) and included pregnant women, both with rRT-PCR
ositive for inﬂuenza A (H1N1). Data were collected from
he national bank for inﬂuenza A (H1N1) reporting system,
uring the epidemiologic weeks (EW) 16 and 41, 2009. Soft-
are employed: Epinfo.
Results: In this period (EW16- 41), we identiﬁed 31,589
uspicious cases of inﬂuenza A (H1N1); from these, 9,350
29.6%) were conﬁrmed, 27% (N = 2,548) in WFY and 26%
n = 668) in pregnant women. The case fatality rate in preg-
ant women was 7.5% (N = 50). The proportion of gestation
n this group is 26%,higher proportion wnen compared with
opulation. The ﬁrst pregnant who died was registered in
he EW 26 and the last one, in EW 39, most of cases were
egistered during WE 28 and 29. Risk factors associated
ere: chronic diseases: cardiopathies OR 2,5 IC95%1,2-5,3;
mmunosuppression OR 2,7 IC95% = 1,5-5,0; metabolic dis-
ases OR 4,9 OC95% 2,5-9,7 and renal diseases OR 3,2
C95% 1,2-8,5. Among the women during their fertile years,
regnancy was not associated to the deaths OR 0,9 IC95%
,7-1,3. In pregnant women there was an association to
eath with the second and third trimester of pregnancy OR
,3 IC95% = 1,3-14,1.
Conclusion: These results conﬁrmed that pregnant
omen should be included in at-risk dor more severe dis-
ase. For death, the risk is more important after second
rimester. It is essential to alert people and doctors that
regnant women should have better control of healthy con-
itions, and start immediately antiviral if they develop
ymptoms of inﬂuenza like illness. This group should also
e prioritized for inﬂuenza vaccination
oi:10.1016/j.ijid.2010.02.1700
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he impact of the ‘‘novel’’ inﬂuenza A (N1H1) pandemic
n Norway, as monitored by recorded fatal cases - end of
ctober 2009
. Hasseltvedt
Sykehuset Innlandet Trust, Lillehammer, Norway
Background: This paper deals the with impact of the
andemic of ‘‘novel’’ inﬂuenza A (N1H1), in Norway, as
ocumented by experiences from the end of April 2009 to
he end of October 2009, as monitored by recorded fatal
ases, during the six months up to October 25, 2009. From
he 1980 s the excess mortality from ‘‘seasonal ﬂu’’ has
een estimated ranging from 1000 to 1500 cases during
he time span of the outbreak. The duration of ‘‘seasonal
u’’, caused by inﬂuenza virus A has been estimated to be
pproximately 10 weeks. The Norwegian projections given
y The Directorate of Health, on April 27, 2009 (source-
RL: dagsavisen.no) gave a scenario of: up to a possible 13
00 deaths - and up to 1.2 million infections — caused by
‘novel’’ inﬂuenza virus A (H1N1).
